Clinical Trial Update: Comparison of HRS-5965 Capsules and Tablets in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 trial comparing capsule and tablet formulations of HRS-5965 in healthy subjects has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iga Nephropathy
• Paroxysmal Nocturnal Hemoglobinuria

Drugs mentioned

• HRS-5965

Snippet

Sponsor: Chengdu Suncadia Medicine Co., Ltd. | Conditions: Paroxysmal Nocturnal Hemoglobinuria，IgA Nephropathy | Phase 1 | Status: COMPLETED